Schjesvold, Fredrik Hellem
101  Ergebnisse:
Personensuche X
?
2

Pomalidomide, bortezomib, and dexamethasone at first relaps..:

Richardson, Paul G ; Schjesvold, Fredrik Hellem ; Weisel, Katja...
Richardson, Paul G. Schjesvold, Fredrik Hellem Weisel, Katja Moreau, Philippe Anderson, Larry D. White, Darrell Rodriguez-Otero, Paula Sonneveld, Pieter Engelhardt, Monika Jenner, Matthew Corso, Alessandro Dürig, Jan Pavic, Michel Salomo, Morten Beksac, Meral Oriol, Albert Lindsay, Jindriska Liberati, Anna Marina Galli, Monica Robak, Pawel Larocca, Alessandra Yagci, Munci Vural, Filiz Kanate, Abraham S. Jiang, Ruiyun Grote, Lara Peluso, Teresa Dimopoulos, Meletios . Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. European Journal of Haematology. 2022, 108(1), 73-83.  , 2022
 
?
5

Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newl..:

Stokke, Caroline ; Nørgaard, Jakob Nordberg ; Feiring Phillips, Hilde...
Stokke, Caroline Nørgaard, Jakob Nordberg Feiring Phillips, Hilde Sherwani, Alexander Gul Nuruddin, Syed Mohammad Connelly, James Pattrick Schjesvold, Fredrik Hellem Rootwelt-Revheim, Mona Elisabeth . Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients. Molecular Imaging and Biology. 2022, 24(5), 842-851.  , 2022
 
?
7

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethas..:

Dimopoulos, Meletios A ; Schjesvold, Fredrik Hellem ; Doronin, Vadim...
Dimopoulos, Meletios A. Schjesvold, Fredrik Hellem Doronin, Vadim Vinogradova, Olga Quach, Hang Leleu, Xavier Montes, Yolanda Gonzalez Ramasamy, Karthik Pompa, Alessandra Levin, Mark-David Lee, Cindy Mellqvist, Ulf Henrik Fenk, Roland Demarquette, Hélène Sati, Hamdi Vorog, Alexander Labotka, Richard Du, Jichang Darif, Mohamed Kumar, Shaji . Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial. Blood Cancer Journal. 2022, 12(1).  , 2022
 
?
 
1-15